87 related articles for article (PubMed ID: 7646991)
1. Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia.
Haj MA; Neilly IJ; Robbie LA; Adey GD; Bennett B
Br J Haematol; 1995 Jul; 90(3):541-7. PubMed ID: 7646991
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
Robbie LA; Dummer S; Booth NA; Adey GD; Bennett B
Br J Haematol; 2000 May; 109(2):342-8. PubMed ID: 10848822
[TBL] [Abstract][Full Text] [Related]
3. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
4. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
5. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
Mesters RM; Flörke N; Ostermann H; Kienast J
Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Yoshida T; Aoshima K; Matsuda T
Eur J Haematol; 1995 Mar; 54(3):176-9. PubMed ID: 7720838
[TBL] [Abstract][Full Text] [Related]
7. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
8. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients.
Haj MA; Robbie LA; Adey GD; Bennett B
Thromb Haemost; 1995 Dec; 74(6):1528-32. PubMed ID: 8772232
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients.
Svaldi M; Hirber J; Lanthaler AI; Mayr O; Faes S; Peer E; Mitterer M
Br J Haematol; 2001 Oct; 115(1):53-7. PubMed ID: 11722409
[TBL] [Abstract][Full Text] [Related]
11. TAFI and PAI-1 levels in human sepsis.
Zeerleder S; Schroeder V; Hack CE; Kohler HP; Wuillemin WA
Thromb Res; 2006; 118(2):205-12. PubMed ID: 16009400
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
Huber K; Beckmann R; Frank H; Kneussl M; Mlczoch J; Binder BR
Am J Respir Crit Care Med; 1994 Oct; 150(4):929-33. PubMed ID: 7921465
[TBL] [Abstract][Full Text] [Related]
17. Tight glycemic control may favor fibrinolysis in patients with sepsis.
Savioli M; Cugno M; Polli F; Taccone P; Bellani G; Spanu P; Pesenti A; Iapichino G; Gattinoni L
Crit Care Med; 2009 Feb; 37(2):424-31. PubMed ID: 19114908
[TBL] [Abstract][Full Text] [Related]
18. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
[TBL] [Abstract][Full Text] [Related]
19. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
20. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Chudý P; Kotuličová D; Staško J; Kubisz P
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]